Every TAVR patient deserves protection.
Heart teams agree - it's worth protecting patients from any degree of stroke and neurocognitive impairment. See how heart teams apply cerebral embolic protection to their programs.
What do TAVR Patients Fear Most
Rose Hansen, VCC, and Dr. David Rose, Neurologist, discuss why patients fear stroke more than any other TAVR consequence.
Even Minor Strokes Matter
Neurologist Dr. David Rose sees the devastating effects of stroke every day. Hear him discuss his experience with TAVR and stroke, along with insights from Rose Hansen, VCC.
Why I Believe in SENTINEL™
Dr. Ramon Quesada (IC), Dr. David Rose (neurologist), and Rose Hansen (VCC) tell us why they believe in Protected TAVR™ with SENTINEL.
Low Risk is Still Risk
Dr. Abhijeet Dhoble (IC), Rose Hansen (VCC), and Dr. David Rose (neurologist) share why low risk is still risk.
CRT Virtual Conference
The final TAVR-focused session of the CRT virtual conference featured several presentations highlighting the ACURATE neo2™ and SENTINEL CPS technologies.
Dr. Rinaldi Presents SENTINEL Update at CRT Virtual 2021
Dr. Mike Rinaldi discusses cerebral embolic protection utilization and benefit in an analysis of recent clinical data from his practice at Carolinas Medical Center.
Calcium Burden in Low Risk Patients - SENTINEL LIR Registry Presentation by Dr. Aloke Finn at Virtual CRT 2021
Dr. Aloke Finn (CV Path Institute) presents findings from the SENTINEL Low and Intermediate Risk (LIR) Registry.
ACURATE neo2 is an investigational device and restricted under federal law to investigational use only. Not available for sale.
All photographs taken by Boston Scientific. Illustrations for informational purposes only – not indicative of actual size or clinical outcome.
All trademarks are property of their respective owners.